Autoimmunity and Coronary Artery Disease - Ancillary to CARDIA
|ClinicalTrials.gov Identifier: NCT00106483|
Recruitment Status : Completed
First Posted : March 25, 2005
Last Update Posted : March 19, 2015
|Condition or disease|
|Cardiovascular Diseases Coronary Disease Heart Diseases|
Connective tissue diseases have been identified as risk factors for coronary artery disease (CAD). Patients with connective tissue diseases such as rheumatoid arthritis and systemic lupus erythematosus have a high prevalence of CAD and are younger than expected at the onset of CAD. It has been proposed that the association between these connective tissue diseases and CAD is related to inflammation. Furthermore, circulating autoantibodies have been identified in CAD and it has been hypothesized that CAD may have autoimmune features. Circulating autoantibodies exist prior to connective tissue disease development and the presence of such autoantibodies in asymptomatic individuals is a predictor of future clinical connective tissue disease. Although the association between connective tissue disease and CAD has been established, an association between pre-clinical circulating autoantibodies and early CAD has not yet been explored.
To test this hypothesis, the following specific aims are proposed using the CARDIA database: 1) Determine the association between autoimmunity measured in stored sera collected in 1992 and the subsequent development of sub-clinical CAD measured in 2000 and 2005. 2) Assess whether autoimmunity measured in 1992 predicts future increased levels of C-reactive protein (CRP) and whether the relationship between autoimmunity and CAD is mediated by CRP level. These aims will be accomplished by a team of investigators within the Division of Rheumatology and Department of Preventive Medicine at Northwestern University. The CARDIA database is a product of the Coronary Artery Risk Development in Young Adults (CARDIA) study, a prospective cohort of 5108 subjects followed since 1985 for development of novel cardiac risk factors. With its extensive epidemiologic database and stored serum collected serially and available from 3500 individuals over the past 20 years, the CARDIA study is an ideal resource for this study.
|Study Type :||Observational|
|Actual Enrollment :||3020 participants|
|Study Start Date :||February 2005|
|Actual Primary Completion Date :||January 2008|
|Actual Study Completion Date :||January 2008|
Coronary Artery Risk Development in Young Adults
There were no interventions.
- Coronary artery calcification (CAC) [ Time Frame: 8 years ]serum samples already collected by they CARDIA study in 1992 were tested by our ancillary study for autoantibodies and we analyzed whether autoantibody positivity was associated with CAC over 13 years of follow up in the CARDIA study. CAC was measured by the CARDIA study in 2000 and 2005.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00106483
|Principal Investigator:||Darcy Majka, MD MS||Northwestern University School of Medicine|